Company registration number.. 10089069 Charity registration number. 1166416 Hannah's Willberry Wonder Pony Charity IA Company limited by guarantee) Annual Report and Financial Statements for the Year Ended 31 March 2024
Hannah's Willberry Wonder Pony Charity Contents Trustees. Report 110 11 Reference and Administrative Details 10 Independent Examinerfs Report 12to13 Statement of Financial Activities 14 Balance Sheet Statement of Cash Flows Notes lo the Finanaal Statements 171023
Hannah's Willberry Wonder Pony Charity Trustees, Report Thè trustees, who are directors for the purposes ol company law, presenl the annual report together with the financial slalements of the Charitable company for the year ended 31 March 2024. Oblectlvès and aetlvltlgs Ourpurpose Hannah's Willberry Wonder Pony Charity seeks lo provide a public benefit by.. promoting research into the causes, prevention and treatment of bone cancer and other ty$ of ancer- promoting the hgallh and wellbeing of people with a disabS11ty or serious Illness., or, ptrople who are affected by the disability or serious illn855 of a close family member., or, people who are suffering from bereavement following the death of a close family mernber, by providing or assisting in the provision of opportunilies to ride or enjoy other equestrian related experiences-, and assisting in the treatmènt and care ol pgopI8 suffering from bone cancgr and other types of cancer and to help people caring for them. The Charity can provide: grants lo organisalions carrying out research into bone cancer. provided that the results of the research funded will be published. In the event that the Charity is not the sole funder of any research then the grant of funding will be subject lo a Condition that res(>lts of resoarch will be published and available for general use- grants lo organisalions, indiwduals and their families lo assist those affected by bone cancer and other types of cancer.. an experience of an equestrian naturo our Willberry'5 Wishes team. making precious memories to treasure forever. Ba¢kgmund Hannah Francis founded the Charity, Hannah's Willberry Wonder Pony. in March 2016, having been di8gnosed with 051eosarcoma the year before al just 17 years old. She wanted to leave a legacy and help people like her who are affected by a serious illness and wanted the Charity lo raise money to fulfil 0 principal objectives.. lo fund research into osleosarcoma I'willberry's Research),. and to provide equestrian experiences to seriously ill people and their families 1"WillberS Wishes"). The Charity went from strength lo strength under Hannah's leadership and has continued lo grow sinc8 her passing in August 2016, raising more than £2 million lo dale. The Charity has funded a number of significant research projects as Hannah so dearly wished,. she fought so courageously and endured such archaic treatment that she never wanted anyone else lo have lo go IhrL)ugh thi5. Hannah lived lor her horses and whilst she was ill. she licked many equine dreams off her bucket list, and gave her the inspiration for "Willberry's Wishes.. The Charity is granting Willberry's Wishes lo seriously ill people in the hope that these 8xperiances inspiro others in the same way as they did Hannah, bringing a little happiness and hope during the dathest of limès. Pag8 1
Hannah's Willberry Wonder Pony Charity Trustees, Report We the Trustees are grateful lo the thousands of people who have helped with donations, fundraising and spreading the word about Hannah's Willberry Wonder Pony Charity. When necessary, the Charity engages the services of experts to assist wilh the running of the Charity but for ihe vasl majority of the time It has been run by volunl8ers. including the Trusleas, and we arts very proud of &veryone's efforts in keeping the cost of running the Charity to a minimum and thus ensuring maximum funds are available lo apply lo public benefit. However, the need for sorneone lo manage the Charity on a day lo day basis is currently under review to ensure that the Charity continues lo run professionally, efficiently and maximises ils public ben8fil. We are grateful lo our volunleers for th8 finan¢ial prot8ction they give us by giving n)any hours of their time, as wtsll as opening their homes for meetings and providing storage space for our traLling sub5idiarls merchandise stock. Our Activities During 2023124 and Achievements to Oat We believe that the Charity has provided a public benefit in the following ways.. In our eiglh full year as a charity we have raised funds of £83,630 Iprevious year a deficit of £5,880) on income of £156,509 (previous ye8r £103,613). Thi5 Was another Successful year in terms of funds generation, with fundraising efforts delivering good growth in income. We are incredibly grateful for the fabulous fvndraising efforts and donations from so many of our supporters. We also rec8ived gengrous donations from individuals, trusts and other charities. The money raised wll help to providè funds lo meet the Charills objectives and provide public benefit in the years lo come by helping fund bone cancer research and providing Willberrfs Wishes. The trading subsidiary. which sells Willberry branded rnerchandise and donates all of its profits lo the Charily1£24,438 In 2023124, pvIOuS year £12.8371 has had another successful year. Demand remainèd steady for our Berry Ponies for other items which were also sold al equestrian events including Badminton Horse Trials, where some riders still lake lo the cross-counlry course with their berry pony strapped lo their backs, thus giving the Charity continued and valuable public profile. The portfolio ol branded items offered is wnstantly reviewed lo ensure Ihal we keep our followers happy and achieve the be51 financial outcome. During the year, we have provided a numbar of Willbery's Wishes to people who are fighting, or ar8 affectgd by, serious illness. Spending during the year providing these experfences amounted lo £2,250 which included.. A wondorful day at the phènomenal Badminton Hors8 Trials for a k)vèly young lady and her friend. They were wined and dined and had a full day of equestrian magic, especially as il was cross country dayl We even arranged a surprise meeting with Olyrnpic rider, Torn McEwen. who then look them into the presligiDUS stables on the Badminton Eslale where they mel some very famous horses indeed. A special visit from a shetland pony lo meet a very poorly little gid in the hospice. Some carriage driving lessons were arrang&d for a lady who had breast cancer. This is something she had aayS wanted to do. and she had the most amazing experience. "A magical day for a littlg girf wff(h her siblings. a pony play day - Doris, Hannah's Shetland and a small pony for the other children travelled lo meet the family. Lols ol cuddles, grooming. riding and even some racesl Followed with a picnic fea51. 'Pony Fun Day for a brother and sister at a riding school. They gol lo ride a number of ponies and even had a go al mounted gamesl 11 was lovely as they were wlh lols of other children who wtsre a similar age. 'A special little girl had aayS wanted lo leam lo ride so we arranged for a set of riding lessons so sh8 could fulfil her dream. Page 2
Hannah's Willberry Wonder Pony Charity Trustees, Report Wg are extremely fortunate Ihal many wonderftjl people in the equestrian community assist us in providing Wishes al no charge lo the Charity. Since form81ion, many Wishes have been granted and all of these have been very well received by the recipients and we look forward to providing many more. In rgspoct of medical research, we have in place an expert panel to assist the Trust88s In seleeling and analy5ing bontr cancer research projects. The expert panel is headed by Dr Claire Clarkin, Associate Professor of Developmental Biology, University of Soulhamplon. and she is very ably assisted by Dr Alice Goring, who completed a PhD related to Ihe study ol the role of blood vessels in bonè diseases. and they both provide critical assistanc8 lo the Charity in managing the medical research investment process. Wa have continued lo meet a number of clinical and academic specialists in the fi8ld of osteosarcoma research and have made significant progress in increasing the profile of the Charity in the academic and scientific communities, including advertising for PhD studentships wth major universities. As a major milestone and lo mark the in¢redible progress made lo dale, we htsld the fir51 Hannah's Willberry Wonder Pony Charity Research Symposium on Thursday 5th October 2023 in London. And this was no ordinary venue, as we were so fortunate to be able to hold the event al The Goring Hotel, thanks to Hannah's close friend land member of our Research advisory panel), Dr Ai¢e Goring, who also did an amazing job organising lh& day. We welcomed researcher5. 5UPPOrter5 and friends from across the UK for 8 day of osleosar¢oma experiences. Science and discovery. Rachel Francis started the day by telling Hannah's story, from her time as a pony-mad young girl and hugely talented ridar through to her initial symptoms, incorrect diagnoses and tha simply dreadful day when Hannah and her family first heard the word 'osteosarcoma'. She spoke movlngly about every stage of the Irealmenl Hannah endured and the horrifi¢ side effects and lack of hope. And Rachel finished by bringing lo life Hannah's passionate desire lo help others and her enduring positivity and love of life. It was a perfect way lo sel the context for the day that followed because, above all. she highlighted the desperate need for the scientific research Hannah's charily is funding. 11 also reiteraled so articul8lely why Hannah is always at the front of our minds when we are all trying so hard lo fulfil her rich legacy. This was followed by an equally absorblng talk by Dr Polly Bales. Hannah's clinician al Royal United Hospital in Bath. Polly spoke in glowing terms about Hannah's fortilude and endurance, but brought starkly to life the desperately poor treatment outcomes that so many bone cancer patients face. Polly was followed by Matt Clark, who suryived his diagnosis of osteosarcoma when in his late teens. Matt explained how luck played a part in his own diagnosis and Irealmenl and he not only brought further context to why we were all assembled but he has also pledged to help Hannah's charity with a bold fundraising plan for 2024. We then had a busy day of excellent talks from all our PhD projects and il was great lo hear all about th8ir research progress. We also had some more In-depth talks from prominent research leaders, including Profe550r Agi Grigoriadis IKing College London), Dr Helen Roberts (Middlesex University) and Professor Allie Gartland (University ol Sheffieldl, who talked about her team's work with large scale drug screening for new treatments in osteosarcoma, which is funded by the Charity. Our first Research Symposlum was a very emotional but Inspiring day and a lebration of the collective hard work that is ongoing into funding and advancing osteosarcoma Iroalments. Paga 3
Hannah's Willberry Wonder Pony Charity Trustees, Report In total to date, we have identified and committed to ten research projects from leading English Universities that w& are supporting with a combined valug of up lo £933.607. of which £57,323 was spent in the financial year. We are confident that in the coming years we will identify projects from other inslilulions that will assist in the idenlificalion of the causes, prevention and Irealmenl of bone cancer and other types of cancer. These efforts will be significantly enhanced by the recent announcomenl that the Charity will bo working logether with The Bone Cancer Rgsear¢h Trust to offar funding of up to £250,0001£125,000 fundtsd by each charity) to support projects focused on improving outcomes for osteosarcoma patients. The lead time for identifying, reviewing, approving and funding research projects remains up lo 2 yaars. The Trusle8s arè very ¢ons¢ious of th8 need to sè16Ct prospéctive resèarch projects carefully and lo ensure the Charity's money is investèd In a consid8red and approprlale way. Our Strategy Going Forwards The Trustees continue lo review the strategy of the Charity lo ensure that il provides public benefit and has the ability to meet its objectives. The Trustees are hopeful that income generated in 2024125 will meet our targ&t of £100.000 and this, 109ether with our strong reserves, will onable us lo carry out the Charity's objectives in futur8 years. As mentioned above, the Charity has since formation entered into, or is about lo enter into, agreements lo furid len research projects. Thg projects that we have funded, or are currently funding, are listed below-. oThe first is with the renowned Department of Oncology and Metabolism al Sheffield University which ran until the end of 2023, with a totsl cost of up to £210,000. The project can be summarised as follows.. As a result ol fundlng from WlllberTVs R&sear¢h, a team comprising a Post-Docloral Researcher (Luke} and a Ipart fundedl PhD Sludenl Iviclorial, led by Professor Alie Gartland, is lesling over 5.000 existing dTU9S and compounds lo assess their effectiveness in killing osteosarcoma cells. The team hopes lo identify polentially useful new drugs and pathways lo develop more effective treatments to improve pabenl respons6s. Because the drugs being s¢reened have already been approved for huinan use, the idenlificalion of new drug candidates could potentially b8 more timely and reach the clinic in a much shorter lime as a result. The main current therapeutic approach for osteosarcoma is a combination of methotrexate, docorubicin, Cisplatin, andlor ifosfamide associated with surgery. Unfortunately, not all patients respond lo these chemotherapy drugs, as their tumour becomes 'chemo-resislanl' and their overall year sutvival rate is drastically redLJcèd. The need for alternative, more effective treatments lo ncrease the survival rates of osteosarcoma patients is cl8ar. The scientific team being funded by Willberry's Research is using 'High Ihroughpul screening, lor HTSI of compound 'libraries' to identify whether existing drugs can be used in osteosarcoma. Excitingly, out of the 4,400 drugs which have been Screened so far, 550 have been found lo have a negative effect on the growth of osteosarcoma cells Igrowng in a dish) at high doses. Page 4
Hannah's Willberry Wonder Pony Charity Trustees, Report o The Charity has also part-funded a PhD student al, Sheffield University, Manchester Univtsrsity and vo at the University of Soulhamplon, with a eornbined funding of £183,000 over 3 years. All four projects were focussed on Osleosarcoma. o Hannah Smith was our first PhD slud6nl and bas8d at Southampton University &upetvised by Prof Stephen Beers Dr Juliet Gray snf Dr Janos Kanzcelr. Osteosarcoma is the most common bone sarcoma in adolescents and has a poor outlook. Novel Irealmenls for this POOTly mel patient group are ¢learly needed bul their development is hampered by the complexity of the disease and the environment in which il grows. Hannah was developing 3D models of osteosarcoma to gain a better understanding of the inlera¢lions between the os180s8rcoma tumour and its SLJrrounding ènvironment. Osteosarcoma is an in¢redib5y Complex type of cancer and currently very little is known about the environment in which it grows. This project focused initially on the drug mifamurtide (also known as Mepactl which is used in palienls, bul to which not all respond. to understand how this drug works and potentially how lo make il work bell6r in more patients. Her PhD is lo develop a 3D model of osteosarcoma, which will enable the testing of new drugs and Ihorapies. This is done by using bone from patients who have had hip replacement surgery and inserting osle05arcoma cells into thesa bone cores. These cores are then positioned to enable blood vessels to inleracl with the bone, so that osteosarcoma ¢8lls remain alive, and the effe¢l of different therapies can be tested. o Another project at Soulhamplon UnNersity, with Belle Creilh a5 a PhD student, started in October 2019 and was supervised by Dr Claire Clarkin, Professor Richard Oreffo and Professor Sumeet Mahajan. This was focused on the earfy delection of osteosarcoma, which is so important, as we are only loo aware how quickly this cancfjr can sprgad. The project has b88n using some very advanced imaging techniques lo look al the fibrès which are prtssenl wilhln osteosarcoma and healthy bone biopsies. Belle is looking al whether diff8rences in these bone fibres in diseased versus healthy bone might be early indicators for osteosarcoma and a measure of meiaslasis. There have been some really good images and findings so far and results of this project should be published soon. o And our PhD project with Manchester University, which also started in October 2019, builds on the success of an earlier 0-year research grant funded by the charity, Friends of Rosie Children's Cancer Research Fund. In common ¥Mth the initial project, our project is being led by Dr Katherine Fineg8n, MRPharmS, with Alex, our PhD sludenl. Pfevious work performed in this lab has found that protein called ERK5 can promote the progression of 051eosarcoma.11 has alsts been found that high levels of the ERK5 protein can increase the chances of chemotherapy resistance and the spread of osteosarcoma around th8 body. Therefore. highèr levels of ERK5 are linked to a reduced chanc8 of survival in patients. Initial evidence has found that. by removing ERK5. lumour cells and immune cells are no longer able lo cornmunicale with each other. This is really p0511ive data from thi5 lab group as it is the communication between the lumour cells and the immune cells which allows the cancer lo spread around the body. 11 is Currently unknown how this happens, but removing ERK5 has shown lo slop the spread of canGer lo the lungs in models of the disease which have been used in the lab. 11 is really important to fully understand how this happens in order to effectively treat osteosarcoma and to develop this treatment for patient use in Ihe future. This projecl aims to find out exactly how ERK5 works in the progresslon of osteosarcoma and determin& whtslher removing ERK5 can improve the response to chernolherapy. This is a promising new avenue for the treatment of osteosarcoma. o Another of our projects is a first fully-fundg(J PhD sludenlship, based at Middlesex University within the Centre for Investigative & Diagnostic Oncology. The resear¢h, led by Dr Helen Roberts (Senior Lecturer), aims to unravel the cornplex cellular and environmental control of how osteosarcoma, the rare type of bone cancer the Charity is focused on, spreads to other tissu8s such as the lungs. Page 5
Hannah's Willberry Wonder Pony Charity Trustees, Report For the past 30 years. survival rates in osleDsar¢r)ma patients have remained unchanged. partly due lo the lack ol rosearch into why the lumour spreads and wh81 initiates this process. Preclinical and clinical ewdence highlights that osleos8r¢om8 lumours likely reside in the bone environtnenl due lo 'proleclive' inleraclions with bone cells. 11 is hypolhesised that disruption ol these protective interactions causes the lurnour to move from the bone lo the lungs in a process called metastasis. The project is investigating why osteosarcoma tumours metastasiso to the lungs and is Ljsing cutting edge ¢ell-based assays lo define not only the role of the bone ce115, bul also the lung environment. The project draws on the tissue engineering experience of Dr Scott Roberts Isenior Lecturer in Tran51alional Skeletal Research, RVCI, who has spent over a decade developing laboratory grown tissues Ihat can be used for regenerative medicine and the investigation of disease processes. Here is an update from our res8ar¢her'. "Our project aims lo identify how 051eosarcoma cells spread lo other tissues such as the lungs. We have identified spheroid-like structures formed from osteosarcoma cells which we have termed 'Migralory Bodies,. These Migratory Bodies divide, reattach. and express increased gene expression of st8m cell markers. sugg&sting that they contain tumour inilialing Ican¢er slèml cells and are therefore an ideal model for sludwng how osteosarcoma ctslls spread lo other 11sSUtrS. We have also looked al the effect of secreted factor5 from two types of bone cells on osteosarcoma cell migration. The data show Ihal when osteosarcoma cells are cultured with factors secreted by osteoclasts (cells that break down bonel and mesenchymal slromal cells IMSCS,. ¢&lls wilh Ihe unique abilily lo develop into specialised cell types). Migratory Body fomalion is suppressed. Thus, we believa that both MSC5 and osleo¢l8s1s secrete factors that modulate Migratory Body formation and thus osteosarcoma cell rnigration. By investigating these findings further, we hope to understand some of the mechanisms that allow osteosarcoma to spread to other tissyes.. o In addition. we are currently funding a PhD project wth Kings College London This is a Ihree-year research project which is taking place under the expert guidance of Professor Agarnemno Grigoriadis. The project is focusing on understanding and preventing the growth of cancer cells in osteosarcoma patients. as well as looking to stop the spread of cancer around th6 body. The ability of osteosarcoma to m&taslasise is what makes il so aggressive and therefore focusing the research on this is really important. This project 15 looking al repurposing a prtrexisling drug, which is currently used lo Ireal neonatal jaundice, lo block the action of F+O-1. HO-1 is a factor which is produced by osteosarcoma patients and prevents the activation of the immune syslem. By 'kick-starting' the immuno system inlo a¢lion, the project will assess il Ihe chemotherapy dwgs are able lo fight the cancer and slop il from moving to other areas of the body. o The Charity has recendy invited follow-on projects from the initial tranche of resgar¢h idgntified above and we are pleased lo confirm 2 four-year PhD sludenl grants have been awarded for a lolal value of £245,000. The projects are.. o Middlesex University {Dr Helen Roberts) - lh8 reS9ah projgct entillgd Suppress Osteosarcoma.. Targeting 0steoclas1-Tumour Interactions to suppress Osteosarcoma metastasis. There is a hypothesis that Osteosarcoma establishes itself in bones by interacting with osleoclasls. specialised cells responsible for breaking down bone tissue. Disrupting this interaction allows OS lo spread to the lungs. In our prior study, we identified 'Migralory Bodies, IMBS) as 8 valuable laboratory model for sludwng OS spread. Osleoclasl factors slow down MBS, bul the drug zoledronic acid (used lo Ireal osleoporosisl can counteract this effect. In the proposed study we will use genetic engineering. to unravel how OS spreads, with a particular focus on polenlial Irealmanl tsrgels STAT3 and MMP9. Additionally, we plan to examine OS rnetabolism and employ a unique model to enhance OL+r understanding of melasiasis. This research holds promise for refining OS Irealmenl slralegies, incorporating insighis into osteoclast interactions, wilh the ults'male goal ol improving oul¢omes for patients. Page 6
Hannah's Willberry Wonder Pony Charity Trustees, Report o King5 College London IProfessor Agamemnon Grigoriadisl - a Novel FGFR-HO-1 Axis for Targeting Osteosarcoma Palhogenesis and Melaslasis. Osteosarcoma 15 a devastating malignancy that affects Children. Metastalic disease remains the most important prognostic indicator of survival, and despite advanc8s in adjuvant chemotherapy and limb-sparing surgery. 5-year survival is 60-70%, dropping lo -200/0 with metaslali¢ disease, and these frequen¢i8s have not improved. We have malle recent progress from an ongoing HWWPC-funded project that is idenlfying a novel largel for OS melaslasis therapy. The enzyme. HO-1, is made by cells in the lumour immune environment Ihal are normally hijacked by tumour Cells lo evade the immune system. Using a drug called SnMP that slops HO-1 from working, this reduces OS melaslasis in m(>dels by reactivating the immune system. enabling killing of lumour ce115. The ¢urrenl HWWPC proposal aims lo follow on from this work, lo show that this HO-1 pathway interacts with a target in lumour cells themselves, called FGFR. We have shown thal blocking FGFR in tumour cells can inhibit melaslasis but whether this affects the inlera¢tion of lumour cells with th8 mi¢roenvironment is not known. This project will ostablish for the first time whether these pathway5 communicate and cooperate with each other lo drive OS mela5tasis. This will open the door lo novel combinatorial therapies using multiple drug combinatsons that will reduce metastatic burden and increase patient Survival. o In addition the Iruslees are excited to confimi that the Charity will be working logglher wlth The Bone Cancer Research Trust lo joint fund a posldocloral 3 year research project of up to £250.000 1£125.000 lunded by each charity) in the 2024125 academic year with Imperial College London led by Dr Jun Ishihara lo support projects focused on improving outcomes for osleDsarcoma patients. Treatment for osteosarcoma has not changed for several dacadas and still relias on a cocktail of toxic ¢hemotherapies. New, largeled Irealmenls, with less immediate and long-lem) effects are desperately needed lo ensure mor8 patients survive and thrive after treatment. Imrnunotherapy is emerging as an effective treatment in many Canr$ and works by helping the immune system find and attack cancer ¢811s. With Ireaimenl options for osteosarcoma patients remaining unchanged for decades il's vital that we investigate options such as immunotherapy for our palianls and try lo translatè the progress being made in other cancers to osl&osar¢oma. We're delighted to be able lo do this in collaboration with the Bone Cancer Research Trust who wholeheartedly have the same aim as LSS. to offer osteosarcoma patients kinder and more effective treatment options.. o A protein named inl&rleukin-12 IIL-121 is known lo successfully aclivale anli-lumour immune ceSls against several cancers. However, despite showing sliong antilumour a¢tivily, IL-12 also induces severe toxicity lo other tissues. Dr Ishihara has successfully been able lo redu IL-12's toxicity by incorporating an addibonal fragment Itumour-largeled domain - TTDI to the IL-12 protein thal enables ils delivery selectively to the tumour, ThD-IL-12 a¢¢umulales in the lumour due lo the targeted protein being present in the lumour's blood vessels. TTD-IL-12 is effective in laboratory models for other cancer types and in initia1 osteosarcoma laboratory models. This project aims lo extend the results found in other Cancers to a full range of laboratory models of osleosarcoma. The research also aims to delerrnine if a ¢ombinalion ol TTD-IL-12 wrth doxorubicin {part of the current MAP chemotherapy regimel can offer additional benefit. In respect of WillberS Wishes, th8 Charity has a small team of volunle8rs ¢Jedicaltrd to helping organise and provide these equestrian-relaled Wishes. Interest is growing and is expected lo continue to do so, as word has spread about how we can help seriously ill people and their families during the darkest of limes by giving them experiences to look forward lo, whilst making memories for all those involved. We share details of some of the vital Wishes we grant, bul other recipi8nls understandably wish to keep them private. We are immensely grateful for the continued support of so many pgople and organisalions in the equestrian worfd, as this is critical in supporting our ability lo provide Willberry'5 Wishe5. Willberry's Wishes helps so many people, not only the Wishee bul also their families, and we alway5 have a number of Wishès that we are working on. Page 7
Hannah's Willberry Wonder Pony Charity Trustees, Report .Willberry's Wishes is about making memories, giving people things to look forwar(S lo and lo for9el yvhal is happening lo them even if it is just for a little while. We hope lo help lols of people by grants'ng many more Willbery's Wishes. Financial review The following section on Financial Review and Future Developments const'tules the Slrateglc Report for Ihtr purpose5 of the Companie5 Act 2006 and the Iruslees confirm that they have complied with the requirements of section 4 of the Charities Act 2011 to have due regard lo the public benefit guidance published by the Charity Commission for England and Wales. In its eighth year of opgralion, the Charfty generated a surplus of £83,630 (previous year a deficit of £5,8801, all of which were unreslricled fund5. The Charitys main Source of finance is donations. with a Signifint ¢onlribution also being made from the trading subsidiary. Re5erve5 policy The Trustees of the Charity have reviewed the Charivs reserve5 policy in line wlh the existing commitments and intended future commilmenls lo osteosarcoma research, Willberry's Wishes and estimates of future administration costs. At 31 March 2024. resfjtves stood at £1,618,9871£1,535,357 in the previous yearl which was subslanlially more than the amount required lo meet these commilmenls. These funds are held in low risk deposit accounts with various financial inslilulions. As previously highlighted, the Charity has committed to date lo expenditure on len osteosarcoma research projects with a value of £933,607, of which £516,137 has b8gn sp8nt and the balance of £417,470 is committed expenditure over the next 4 years. The Charity is cUentlY in the prOsS of preparing for the invitation of applications for ftjrther project funding requests from the research community, with the aim of awarding more lully funded research projects. It is anticipatèd ihat there will be at least 2 new projects costing a Combined £250.000 lover 4 years) Committed lo in each of the next 3 years. In addition. as sialed above, the Trustees are excited to confirm that the Charity wll be working together with The Bone Cancer Res8ar¢h Trust lo offer funding ol up lo £250.000 (£125,000 funded by each charity) in the 2024125 acad8mic year lo support projects focused on irnproving outcomes for osteosarcoma patients.11 is anticipated that this working relationship will directly lead to further research opportunities in futur8 years with the aim of wmmitting to further larga Icir¢a £250,000) projects, jointly funded circa £125.000 by each charity. In addition the Charity wll continue to fund Willberry's Wishes. Conclusion The Trustees believe that the Charity has, through the kind and generous help of our supporters and volunteers, raised funds that will provide a public benefit in years to come through the funding of bong cancer résearch and tho provision of Willberry's Wishes. Pa9e 8
Hannah's Willberry Wonder Pony Charity Trustees, Report Stru¢tur8* governanca and managernent Nature of governlng document The company is a registered charity, number 1166416. and was incorporat8d on 29 March 2016. It IS govemed by the articles and memorandum of association of that date. Thg company is limited by guarantee and wilhoul a share capital. Al Trustees are members of the COpanY and guarantee to contribute to the assets of the company, in the evenl of il being wound up, such amounts as may be requir not exceeding £10. Our Trustsès The Charity is currently run by S Iruslees, including Hannah's parents (Rachel and James Francis) and her grandmother lJune Clolhierl. The other two Trustees are lan Pelers, former Financial Controller of Hanson plc. General Manager of Hanson Europe and Finance Director of Breedon Aggregaltrs PLC, and Miles Toulson-clarke. a former Main Board Director of Williams Lea Group and currently UK CEOIGroup COO of Innovation Group and Dislri¢t Commissioner of the Wylye Valley Pony Club. Each of the Trustees gives their time freely. both in their roles as Trustees and carrying out day lo day iasks in running the Charity. Day to day aclvllles of the Charfty aro delegated to each of the Trustees on a fijnctional basls as follows.. Rachel FranGIS first point of contact. Willberrfs Wishes and fundraising and research. James Francis Willberrfs Wishes, media and communications and research., June Clothier trading subsidiary sales including online and at events and research,. Miles Toulson.Clarke- resfyarch and media and communications., 18n Peters- finance and legal. Induction and training of trustees Before being appointed, a potential new Iruslee is encouraged lo attend a number of Iruslee meetings to familiarise themselves with the work of the Charity. A newly appointed Iruslee Teceives guidance and infom)al training lo enable them lo perform their duties effectively, including governance and management, an induction to Ihg history and current activities of the Charity, code of conduct and charity ethics. New Iruslees are provided with ¢opies of key documents includin9 the Charivs goveming documents, rninules ol recent Iruslees meetings and, once these are available, the latest sel of financial statements and trustees, report. Flnan¢lal In$truments Objectlves and pollcles The Charills activities expose ft lo a number of financial risks, principally liquidity. The Charity does not use derivab've financial inslrumenls. Page 9
Hannah's Willberry Wonder Pony Charity Trustees, Report Liquidity risk and interest rates The Charitls principal financial assets are bank balances and cash. trade and other recèivables, and inveslmenls. Thtr credit risk on liquid funds and derivative financial inslnjmgnts is limited because the counterparties are banks with high credil-ralings assigned by intemalional credil-raling agencies. The Charity has deliberately taken a conservative approach lo investing its available funds during the course of the financial year which, given the current international interest environment. has generated a low ralg of return. There is some residual risk lo the Charity should interest rates turn negative. In order lo maintain liquidity lo ensure (hal sufficient funds are available for ongoing operations and future developments, the Charity has adopted a conservative reserves policy. Reference and Administrative Details Truste8s J S Clothier J R Francis R Francis l A Peters C T M Toulson-clarke Charlty Registration Number 1166416 Company Registration Number 10089069 The chanty is incorporated in England and Wal8S. Manor Fami Hemington Radstock BA3 5XX Reglstered Offi¢e Independent Exarniner PaLJI Giessler FCA Francis Clark LLP Hil¢hGock House Hilltop Park Devizes Road Salisbury SP3 4UF Tho annual report was approved by the tntrstees of the charity on behalf L)y'. ID and signed on ils IAP lers Trustee Page 10
Hannah's Willberry Wonder Pony Charity Trustees, Report Statement of trustees, responsibilities The trustees (who are also Ihtr directors of Hannah's Willbtrrry Wonder Pony Charity for the purposes of company lawl are responsible for preparing the Iruslees, report and the financial slalements in accordar)ce with applicable law and United Kingdom Accounting Standards Iunited Kingdom Generally Accepted Accounting Praclicel, incsuding FRS 102 "The Financia1 Reporting Standard applicable in thg UK and Rèpublic of Ireland.. Company law requires the trustees lo prepare financial slalemenls for each financial year. Under company law the truslees must nol approve the financial slalements unless Ihey are satisfied that Ihoy giv8 a truè and fair viaw of tha state Df affairs of thg charitable company and of the incoming resources and application of resources, including ils income and expenditure, of the charltable company for that period. In preparing these financial stalemenls. the trustees are required to= select suitable accounting policies and apply them consistentty; observe the methods and principles in the Charits'es SORP., make judgements and eslimales th81 are reasonable and prudent., state whether applicable accounting standards, comprising FRS 102 have been followed, sublecl lo any material departu$ disclosed and explained in the financial slalernenls., and prepare the financial slalemenls on the going concern basis unless il is inappropriate to prgsume that the charitable company wll continue in business. The Iruslees are responsible for keeping proper accounting records that can disdose with reasonable accuracy al any lime the financial position of the charitable company and enable them to ensure that th8 financial statements comply with the Companies Act 2006. They are also responsible for safgguarding the assets of the ¢haritable company and hence for taking raasonable steps lor the prevention and delecllon of fraud and other Irregularities. The trustees are responsible for the mainlenance and integrity of the corporate and financial infom)ation included on the Charitable companls website. Legislation goveming the proparalion and dissemination of financial statements may differ from legislation in other jurisdictions. Approved by the trustees of the charity on and signed on ils behalf by.. IAP Trustee P8ge11
Hannah's Willberry Wonder Pony Charity Independent Examiner's Report to the trustees of Hannah's Willberry Wonder Pony Charity ('the Company,) I report lo the charity trustees on my examination of the accounts of tho Company for th8 year ended 31 March 2024. Responsibilities and basis of report As the charity's IDJStees of the Company land also ils directors lor the purposes of company lawl you are responsible for the preparation ol the accounts in accordance with the requirements ol the Companias Act 20061'lh& 2006 A¢l'l. Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination ol your charity's accounts as carried out under se¢lion 145 of the Charities Act 2011 {'Ihe 2011 Acl'l. In carrying out my exarninalion I have followed the Directions given by the Charity Cofnmission under section 14515llbl of the 2011 Act. An independent examination does not involve gathering all the èvidence that would be required in an audit and consequently does not cover all the matters that an auditor considers in giving their opinion on Ihe accounts. The planning and conduct of an audit goes beyond the limited assurance Ihal an independont examination Can provide. Consequently I express no opinion as lo whether the accounts present a 'lrue and lair, view and my report is limited lo those specific matters sel out in Ihg independent exarniner's sl8lemenl. Independent examlner's statement I have completed my examination. I confimi that no matters haye come to my attention in connection with tho examination giving me causg to believe.. 1. accounting rg¢ords were not kept in respect of Hannah's Willberry Wonder Pony Charity as required by se¢tion 386 of the 2006 Act., or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the accounting requirernents of section 396 of the 2006 Act other than any requirement that the accc>unts give a 'true and fair view. which is not a matter Considered as part of an indtspendenl examination,, or 4. the accounts have not been prepared in accordance wilh the methods and principles of the Statemenl of Recommended Pra¢ti¢e for accounting and reporting by charities lapplicable to charities preparing their accounts in accordance wlth the Financial Reporting Standard applicable in the UK and Republic of Ireland {FRS 10211. I hav& no concems and have come across no other matters in connection with the examination lo which attention should be drawn in this report in order lo enable a proper understanding of the accounts to bg reached. Page 12
Hannah's Willberry Wonder Pony Charity Independent Examiner's Report to the trustees of Hannah's Willberry Wonder ny Charity ('the Company,) l Giessler FCA ncis Clark LLP Fr Hitchcock House Hilltop Park Devizes Road SalisbLJry SP3 4UF Dale.. P8ge 13
Hannah's Willberry Wonder Pony Charity Statement of Financial Activities for the Year Ended 31 March 2024 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses) Unrestricted funds Total 2024 Note Income and Endowments from: Donations and legacies Investment income 123.497 33,012 123.497 33.012 Total income 156.509 156,509 Exp•ndltur8 on.. Charitable activities 72,879 72,879 Total expenditure 72,8791 72,879 Nel income e3,630 83,630 Ngt movement in ftjnds 83,630 83,630 Re¢on¢lllation of funds Totsl funds brought forward 1,535,357 1.535,357 Total funds carried fOard 15 1,618,987 1,618,987 Unrestricted funds Total 2023 Not8 Income and Endowments from: Donations and legacies Investment income 91,346 12,267 91,346 12,267 Totsl income 103.613 103.613 Expandltura on: Charitable activities 109,493 109,493 Total expenditure 1109,493 109,493 Nel expenditure 5,880 15.880 Nel movement in funds 15,880) 15,8801 Reconciliation of funds Total funds brought forward Total funds carried foTward 1.541.237 1,541,237 15 1.535,357 1.535,357 l of the charity's activities derive from continuing operations dudng the above two periods. The funds breakdown for 2023 is shown in note 15. Th8 notes on pages 17 10 23 form an integral part of th858 fin8ncial stat8m8nt5. Page 14
Hannah's Willberry Wonder Pony Charity Statement of Financial Activities for the Year Ended 31 March 2024 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses) Unrastricted funds Total 2024 Note In¢omo and Endowments from: Donalions and legacies Investment income 123,497 33,012 123.497 33,012 Total income 156,509 156,509 ExndIture on.. Charitable aclivilies 72,879 172,879 Tota5 expenditure 172,879 172,8791 Nel incorne 83,630 83,630 Nel movement in funds 83.630 83.630 Recon¢lliation of funds Total funds brought forward 1,535.357 1.535,357 Total funds carfed foward 15 1,618,987 1.618,987 Unrestricted funds Total 2023 Not• Income and Endowments from: Donation5 and legacies Inveslment income 91.346 12.267 91,346 12,267 Total income 103,613 103,613 Expandlture on.. Charitable activities 109,493 109,493 Total expenditure 109,493 109,493 Net expenditure 15,880 5,880 Net movement in funds 15,880) 15,8801 Reconciliation of funds Total funds brought forward Total funds carried forward 1,541,237 1.541.237 15 1,535,357 1.535.357 All of the charity's activities derive from conlinuirwJ operations during the above two peri¢xls. The funds breakdown for 2023 is shown in note 15. The notes on pages 17 to 23 form an integral part of Ih85e financial Statements. Page 14
Hannah's Willberry Wonder Pony Charity (Registration number: 10089069) Balance Sheet as at 31 March 2024 2024 2023 Not• Fixed as$trts Investments Current assets Debtors Cash al bank and in hand 10 27,638 1.605,355 12,837 1,543,324 1.632,993 1.556,161 Credltors: Amounts falllng due wlthln on¢ yoar 12 14,007 20,805 Net ¢urr¢nt as$ot$ 1.618,986 1.535,356 Net a$$ets 1.618.987 1,535,357 Funds ofthe charfty: Unrestrictèd incoma funds Unreslricled funds 1.618.987 1.535,357 Total fund$ 15 1,618,987 1,535.357 For the financial year ending 31 March 2024 the Charity was enliU8d lo extsmplion from audit under section 477 of the Companies Act 2006 relating lo small companies. Directors, responsibil+ties'. The member5 have not required the charity lo obtain an audit of its accounts for the year in question in accordance with section 476.. and The directors a¢knOedge their responsibilities for complwng wllh the reqL¢lrements of the Act respect lo accounting record5 and the preparation of accounts. The fin statements on pages 14 to 23 w8r8 approved by the trustèes, and authorised for issue .L.¥and signed on their behalf by.. elers Trustee The notes on pages 17 10 23 fom an Integral part of these financial statements. Page 15
Hannah's Willberry Wonder Pony Charity Statement of Cash Flows for the Year Ended 31 March 2024 2024 2023 Not8 Cash flows from operatlng actlvltles Nel cash incomellexpendilurel 83,630 15,880) Adjustments lo cash flows from nonwcash Items Investment income 133,012 50,618 12.267 118.1471 Worklng capltal adjustsnents Ilncreaseydecrease in debtors {Deea$@yIn¢re8s8 in ¢rgdilors 10 12 114,8011 6.798 7,284 17,805 Ngt cash flows from operating activities 29,019 6,942 Cash flows from Investing a¢tivitie$ Interest receivable and similar income 33.012 12,267 Net increase in cash and ¢ash equivalents 62,031 19,209 Cash and cash equivalents at 1 April 1,543,324 1,524.115 Cash and cash equivalents al 31 March 1,605,355 1,543,324 All of the cash flow5 are derived from continuing operations during the above iwo periods. Th8 notes on pages 1T io 23 form an Integral part of these financial staiements. Page 16
Hannah's Willberry Wonder Pony Charity Notes to the Financial Statements for the Year Ended 31 March 2024 1 Charlty status The charity is litnited by guafanlee, incorporated in England and Wales, and consequently does not have share capital. Each of the Iruslees is liable lo contribute an arnounl not exceeding £10 towards Ihe assets of the charity in the event of liquidation. The address of ils registered office is.. Manor Farm Hemington Radslock BA3 5XX 2 Accounting policies Summary of slgnlflcant accounting pollcles and key accountlng estlmates The principal accounting policies applied in the preparation of these financial statements are sel out below. These policies have been consistently applied to all the years presented, unless otherwise staled. statament of compllance The financial slalemenls have been prepared in accordance wilh Accounting and Reporting by Charities.. Statement of ReconTrmended Practice (applicable lo charities pparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 10211 (issued in October 20191- (Charities SORP IFRS 10211. the Financial Reporting Standard applicable in the UK and Republic of Ireland {FRS 1021 and the Companies Act 2006. Basls of preparatlon Hannah's Willberry Wonder Pony Charity meets the definition of a publlc benefit entity under FRS 102. Assets and liabilities are initially recognised al historical cost or transaction value unless olheNise slated in the relevant accounting policy notes. Golng concern The trustees consider that there are no material uncertainties about the Charity's ability lo continue as a going concom nor any significant areas of uncertainty Ihal affect the carying value of assets hgld by the charity. In¢om• and endowments AJI income is recognised once the charity has enlillement lo the income, il is probable that the income will be rgcèived and the amount of the income receivable can be measured reliably. Donations and legacies Donations and legacies are recognised on a receivable basis when receipt is probable 8nd the amount can be reliably measured. Donations received through third party organisalions such as Just Giving are shown nel of any fees charged by these organisalions. Page 17
Hannah's Willberry Wonder Pony Charity Notes to the Financial Statements for the Year Ended 31 March 2024 Expenditure All exp&ndiluf8 is recognised once ther8 is a leg81 or constwctive obligation lo that expenditu, il is probable settlement is required and the amount can be rneasured reliably. All costs are allocated lo the applicable expenditure headirig that aggregate similar costs lo that category. Where costs cannot be directly aitributed to particular headings they have been allocated on a basis consistent with tha use of resources. Charitable activitles Charitsble expenditure comprises those costs incurred by th8 ¢harily in the delivery of ils activities and services for ils beneficiaries. 11 includes both costs that can be allocated directly lo such activities and those costs of an indirect nature necessary lo support them. Grants Grants are recognised al the amount payable when the intention lo make a grant has been communicated to the recipient and the conditions of the gr8nl have been m81. Governance costs Thes& include the costs attributsble lo the charills compliance wth Constltutional and slalulory requirements, including audit, strategic mana9emenl and Iruslees meetings and reimbursed expenses. Taxation The ¢harlty is consldgr&d lo pass the 18sts $81 out in Paragraph 1 Scheclule 6 of the Financg A¢1 2010 and therefore it meets the definition of a charitable company for UK corporation lax purposes. Accordingly, the charity is potentially exempl from laxalion in respect of income or capital gains received within categories covered by Chapter 3 Part 11 01 the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, the extent that such income or gains are applied exclusively lo ¢harilable purpos&s. Fix&d a$$at Invèstm8nl$ Investments in subsidiaries are slated al historical cost sess provision for any diminution in value. Cash and cash equlvalents Cash and cash equivalents comprise cash on hand and call deposits, and other short-lerm highly liquid investments that are readily convertible to a known amount of cash and are subject lo an insignificant risk of change in value. Fund structure Unreslricled income funds are general funds that are available fof use al the trustees discretion in furtherance of the objectives of the charity. Page 18
Hannah's Willberry Wonder Pony Charity Notes to the Financial Statements for the Year Ended 31 March 2024 3 Income from donatlons and lega¢les Unrestricted funds Ggnoral Total funds Don81ions and legacies., General (5onalions Donation from trading subsidiary 99,059 24,438 99,059 24,438 Total for 2024 123,497 123,497 Total for 2023 91,346 91,346 4 Investment Income Unrèstrictad funds Gènèral Total funds Interest receivable and similar income., Interest reIvable on bank deposits 33,012 33.012 Total for 2024 33,012 33,012 Total for 2023 12,267 12.267 5 Expenditure on charitable activltlès Unrgstricted funds General Total funds Note Grant fijnding of activities Alocaled support costs Governance costs 59,573 7,544 5.762 59.573 7.544 5,762 Total for 2024 72,879 72,879 Total for 2023 109.493 109,493 In addition to the expenditure analysed above, there are also govemance costs of £5,762 12023 £4,213) which relate directly lo charitable aclivilies. See note 6 for further details. Page 19
Hannah's Willberry Wonder Pony Charity Notes to the Financial Statements for the Year Ended 31 March 2024 6 Analysls of govemancè and Support ¢o$t$ Charltablo a¢tlvities exp¢ndltur• Unr•$trlct&d Total 2024 Total 2023 General Office expenses Insurance Legal and professional fees Printing, postage and stationary Bank fees Govemance costs IT related costs 2.000 1.227 35 2,000 1.227 35 1,618 545 44 2,073 4.213 3,448 5,762 830 3,448 5,762 830 13,306 13,306 8,493 Govornanc8 ca$ts Unre$lrlcted funds General Total funds Independent examiner fees Examination of the financial slalements Other fees paid lo examiners 2.915 2,847 2,915 2,847 Total for 2024 5.762 5,762 Total for 2023 4,213 4.213 7 Trustees remuneration and expenses During the year the charity made the following transactions with Iruslees.. Two Iruslees received reimbursed travel and subsistence of £26712023 £1.3811 durin9 the year. No trustees, nor any persons connected with them. have reived any remuneration from the charity during the year. Pagè 20
Hannah's Willberry Wonder Pony Charity Notes to the Financial Statements for the Year Ended 31 March 2024 8 Independent examinerfs remuneration 2024 2023 Examination of the financial slalemonts 2.915 2,650 Other fèes to examlners l other services 2,847 1,563 9 Flx•d assgt Invo$tments 2024 2023 Shares in group undertakings and parbcipaling inlgr8sIs Datalls of und8rtakings D8tails of the investments in which the charity holds 20% or more of the nominal value of any dass of share capital a as follows.. Country ¢f incorporation Proportlon of votlng rights and shares held 2024 2023 Prlnclpal actlvlty Undertaking Holding Subsldlary undertakings Sale of merchandise and soft toys branded with Hannah's Willberry Wonder Pony The Willberry Wonder Pony Trading Company Limited Manor Farm. Heminglon, Radslock,BA3 5XX England and Wales Ordlnary 100% 100Q Subsldlarles Thè trading subsidiary Company donates ils profits lo the charity. For the period 1 April 2023 10 31 March 2024. the subsidiarls tumover was £42,000 12023 - £38.6021 and total expenditure wa5 £42.00012023 - £38,602>. Page 21
Hannah's Willberry Wonder Pony Charity Notes to the Financial Statements for the Year Ended 31 March 2024 10 D&btors 2024 2023 Due from group undertakings 27,638 12,837 11 Cash and cash equlval•nt$ 2024 2023 Cash al bank 1,605,355 1.543,324 12 Creditors: amounts falllng due wlthln one year 2024 2023 Accruals 14,007 20,805 13 Analysls of net assets between funds Unro$trl¢ted fund$ General Total funds at 31 March 2024 Fixed asset investrnenls Current assets Current liabilities 1,632,993 14,0071 1,632,993 14,007 Total nel assets 1.618.987 1.618,987 Unr8strl¢t8d funds General Tolal funds at 31 March 2023 Fixed asset investments CLJrrenl assets Current liabilities 1,556.161 20.805 1.556.161 20,805 Total nel assets 1,535,357 1,535,357 14 Related party transactions The charity ha5 taken advantage of the exemption in Financial Reporting Standards 102 chapter 33 "Relatgd Paty Disclosure. and has not disclosed transactions with wholly owned group unlertakings. Donations made by the trustees wilhoul any conditions attached lotalled £415 12023 - £1501 for the year. Pag8 22
Hannah's Willberry Wonder Pony Charity Notes to the Financial Statements for the Year Ended 31 March 2024 15 Funds Balance at I April 2023 Incoming resources Resources Balance at 31 expended March 2024 Unrostrlctèd funds General 1.535,357 156.509 72.879 1.618,987 Balance at 1 April 2022 Incomlng resources Resources Balance at 31 expended March 2023 Unrestrl¢tgd funds General 1,541,237 103,613 109.493 1,53S,357 P8g8 23